YTHDC1 and neoplasm: piR-26441 suppresses mitochondrial oxidative phosphorylation and proliferative capacity in ovarian carcinoma cells via YTHDC1-mediated m6A modification, thereby attenuating tumor metabolic adaptation and growth [97].